StockData
Stryker Corp logo

Stryker Corp (SYK) company profile

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 18/306% below fair value
$317.54+6.82 (+2.19%)

Close on Nov 17, 2026Market cap $120.89BP/E 33.8Yield –

About Stryker

Surgical & Medical Instruments & Apparatus, SIC 3841

Stryker Corporation operates primarily across two operating segments: MedSurg and Neurotechnology, and Orthopaedics and Spine. Its main offerings encompass surgical instruments, endoscopy equipment, medical devices, neurovascular technologies, and neurocranial solutions, as well as knees, hips, spine, and trauma and extremities products. The company also provides customer lease agreements. Stryker serves healthcare organizations, surgeons, hospitals, and clinical specialists.

The company maintains operations and sales activities both domestically within the United States and internationally across non-U.S. locations, including the EMEA region, Ireland, and Germany. The provided annual report excerpts do not disclose the company's specific headquarters location, store counts, or total number of operating facilities.

Summary of the business section of Stryker's latest annual report, written by StockData.

Company profile

Company

Legal name
Stryker Corp
Founded
1946
Headquarters
Portage, MI
Address
1941 Stryker Way 49002
Phone
(269) 385-2600
Employees
56,000, Dec 31, 2025
Industry
Surgical & Medical Instruments & Apparatus
Incorporated in
Michigan
Fiscal year ends
December 31
Auditor
Ernst& Young LLP, Grand Rapids, Michigan

Stock & identifiers

Ticker
SYK
Exchange
NYSE
Shares outstanding
381M, Sep 30, 2026
Public float
$144.31B, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
2-for-1, May 17, 2004; 2-for-1, May 15, 2000; 2-for-1, Jun 11, 1996; 2-for-1, Jun 14, 1991; 3-for-2, Jun 20, 1989; 2-for-1, Jun 12, 1987; 3-for-2, Sep 17, 1985; 3-for-2, Nov 15, 1982; 3-for-2, Nov 12, 1980
SEC CIK
310764
CUSIP
863667101
ISIN
US8636671013
FIGI
BBG000DN7P92
Share class FIGI
BBG001S8FR03
LEI
5493002F0SC4JTBU5137
EIN
38-1239739

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Kevin LoboChair and CEO, Director249,444
Preston Wendell WellsVP, Chief Financial Officer3,971
Emily Kay BaculikVP, Corporate Controller1,554
Dylan Bram CrottyGroup President13,711
Debra KingSee Remarks6,218
M. Kathryn FinkVP, Chief HR Officer13,649
Robert S. FletcherVP, Chief Legal Officer10,672
Kimberly Ann MontagninoVP, Chief Comm. Officer1,750
Spencer S. StilesPresident and COO77,720
William E. Berry JrVP, Chief Accounting Officer4,041
Viju MenonGroup President22,298
James Andrew PierceGroup President91,696
Glenn S. BoehnleinVP, Chief Financial Officer13,195
Yin C. BeckerVP, Chief Corp Affairs Officer36,052
Ronda E. StrykerDirector13,917,258
Mary K. BrainerdDirector7,921
Emmanuel Perez MacedaDirector1,322
Rachel RuggeriDirector2,001
Sherilyn S. McCoyDirector7,190
Andrew K. SilvernailDirector18,465
Giovanni CaforioDirector4,530
Rajeev SuriDirector7,190
Tatum Lisa M. SkeeteDirector5,205
Allan C. GolstonDirector18,500

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025$21.40M$24.78M$4.64M$151$148
FY2024$21.98M$48.19M$6.36M$153$129
FY2023$20.77M$42.47M$6.07M$126$126
FY2022$18.56M$11.42M$5.25M$102$124
FY2021$16.36M$27.84M$5.77M$110$126
FY2020$13.32M$24.00M$4.02M$118$113

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryStock awardsOption awardsIncentive payOtherTotalvs. prior year
Kevin A. Lobo
Chair, Chief Executive Officer and President
$1.49M$9.76M$6.92M$2.25M$974.91K$21.40M-3%
Preston W. Wells
Vice President, Chief Financial Officer
$653.43K$1.84M$1.30M$514.56K$103.34K$4.41M–
Spencer S. Stiles
Group President, Orthopaedics
$792.50K$2.69M$1.90M$760.00K$188.08K$6.33M-6%
J. Andrew Pierce
Group President, MedSurg and Neurotechnology
$792.50K$2.69M$1.90M$754.15K$188.08K$6.32M-6%
Viju S. Menon
Group President, Global Quality and Operations
$675.00K$1.65M$1.17M$578.00K$167.48K$4.24M-8%
Glenn S. Boehnlein
Advisor to the Chief Executive Officer and Former Vice President, Chief Financial Officer
$800.00K––$800.00K$293.05K$1.89M-74%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“On December 31, 2025 we had approximately 56,000 employees”

Corporate history

Events identified from SEC filings

DateEventDetails
Feb 19, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 17, 2025Tender offerThird-party tender offer for the company's shares
Dec 3, 2024DelistingNotice of delisting from exchange (Form 25)
Sep 11, 2024ListingRegistration of securities on an exchange (Form 8-A)
Dec 11, 2023ListingRegistration of securities on an exchange (Form 8-A)
Nov 30, 2023DelistingNotice of delisting from exchange (Form 25)
Feb 23, 2022Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jan 25, 2022Tender offerThird-party tender offer for the company's shares
Nov 30, 2020DelistingNotice of delisting from exchange (Form 25)
Nov 16, 2020Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 13, 2019Tender offerThird-party tender offer for the company's shares
Dec 3, 2019ListingRegistration of securities on an exchange (Form 8-A)
Nov 30, 2018ListingRegistration of securities on an exchange (Form 8-A)
Nov 9, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Sep 24, 2018Tender offerThird-party tender offer for the company's shares
Apr 5, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Apr 1, 2016Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 17, 2013Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
May 27, 2011Tender offerThird-party tender offer for the company's shares
Sep 15, 2000DeregistrationTermination of SEC registration (Form 15)
Jun 28, 2000MergerRegistration of securities for a merger or exchange offer (S-4)
Jul 1, 1997ListingRegistration of securities on an exchange (Form 8-A)

See a number that looks wrong?